A randomized, double blind, placebo controlled, four arm (placebo, tolterodine ER [extended release], tamsulosin, and tolterodine ER plus tamsulosin) study to evaluate the clinical efficacy and safety of tolterodine ER 4 mg in men who have frequency and urgency, with or without urinary urge incontinence, with or without bladder outlet obstruction

Trial Profile

A randomized, double blind, placebo controlled, four arm (placebo, tolterodine ER [extended release], tamsulosin, and tolterodine ER plus tamsulosin) study to evaluate the clinical efficacy and safety of tolterodine ER 4 mg in men who have frequency and urgency, with or without urinary urge incontinence, with or without bladder outlet obstruction

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Jun 2011

At a glance

  • Drugs Tamsulosin; Tolterodine
  • Indications Benign prostatic hyperplasia; Lower urinary tract symptoms; Overactive bladder
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Mar 2007 Results data published.
    • 30 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top